7-肖泽芬-医科院肿瘤医院-食管癌综合治疗的进展与思考.pptVIP

* * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * S alone (267 patients 54%) combined therapy （ 223 patients 46%) The 5-year —— 40.3% (全组) The 5-year OS - 38.6% —S alone 42.3% —Combined therapy (p= 0.48) OS of 490 T2 N0 patients （1998 to 2008） Conclusions： Combining R+S did not result in improved outcomes compared with S alone for patients with T2 N0 esophageal cancer in the Surveillance, Epidemiology and End Results database Neoadjuvant Chemoradiation Therapy Is Beneficial for Cl